In clinical trials of SGLT2 inhibitors in type 2 diabetes, discontinuation rates among those receiving active treatment have been less variable, ranging from 21% during a median follow-up time of 50 months in the DECLARE-TIMI 58 trial of dapagliflozin to 29% during a mean follow-up time of 43 months in the CANVAS trial of canagliflozin [14,15,16,17,18]
Understanding insurance coverage for weight loss medications can be challenging, but its always worth rechecking your benefitsespecially if your coverage has changed due to a job switch, adding or removing dependents, or transitioning to a spouses plan
The semaglutide mixing chart for your concentration will tell you how much diluent to add for each desired dose concentration
Improved mobility: Shedding excess weight eases strain on your joints and muscles, making daily activities and vigorous exercise more comfortable
Learn More A secret weapon disguised as a skincare routine